Table 3

Distribution of lymphatic invasion density (LID [nLI/mm2]), peritumoral lymphatic vascular density (P-LVD), and intratumoral lymphatic vascular density (I-LVD) according to clinicopathologic parameters in cases with gastric carcinoma
Variables Mean ± SD (Min.-Max.)
LID P-LVD I-LVD
Histological type
NOS/tubular/papillary 0.06 ± 0.16 (0–0.8) 12.8 ± 2.7 (7.2–15.7) 6.9 ± 4.4 (1–24.3)
Mucinous/poorly cohesive 0.11 ± 0.13 (0–0.8) 13.8 ± 5.4 (5.9–21.6) 6.9 ± 2.6 (3.5–10)
Differentiation
Well/moderate 0.01 ± 0.01 (0–0.03) 10.2 ± 2.7 (7.2–15.7) 5.2 ± 2.1 (1–8.7)
Poorly/signet ring cell 0.10 ± 0.18 (0–0.88) 14.5 ± 6.2 (5.7–32) 6.9 ± 2.6 (3.5–10.2)
pN
N0 0.001 ± 0.003 (0–0.03) 8.1 ± 1.7 (5.9–11.7) 3.5 ± 1.5 (1–5.5)
N1 0.02 ± 0.01 (0–0.04) 8.6 ± 1.9 (5.7–11) 4.8 ± 1.9 (3–8.7)
N2 0.03 ± 0.03 (0–0.02) 12..6 ± 2.5 (9–17.5) 6.8 ± 1.9 (3.5–9.3)
N3 0.18 ± 0.2(0–0.9) 19.1 ± 5.3 (13.7–32) 10.6 ± 4.4 (6–24.3)
pT 0.001 ± 0.003 (0–0.03) 8.1 ± 1.7 (5.9–11.7) 3.5 ± 1.5 (1–5.5)
T1 0.0 ± 0.0 (0–0) 7.9 ± 1.1 (7.2–8.7) 3.9 ± 0.6 (3.4–4.3)
T2 0.0 ± 0.01 (0–0.01) 10.8 ± 7.2 (5.7–16) 6.4 ± 3.2 (4.1–8.7)
T3 0.04 ± 0.05 (0–0.27) 11.8 ± 4.1 (5.9–22.1) 5.9 ± 2.8 (1–11.3)
T4 0.16 ± 0.3 (0–0.88) 19.1 ± 5.3 (13.7–32) 9.6 ± 5.2 (4.3–24.3)
TNM stage
I 0.0 ± 0.0 (0–0) 7.7 ± 0.9 (7.2–8.7) 2.9 ± 1.7 (1–4.3)
II 0.01 ± 0.02 (0.0–0.05) 9.5 ± 2.9 (5.7–16) 4.6 ± 1.9 (1.1–8.7)
III 0.13 ± 0.2 (0.01–0.88) 16.2 ± 5.6 (9–32) 9 ± 4.2 (7.9–11.5)
IV - - -
Total 0.07 ± 0.15 (0–0.88) 13.1 ± 5.7 (5.7–32) 6.9 ± 3.9 (1–24.3)

Karadayı et al.

Karadayı et al. Diagnostic Pathology 2013 8:151   doi:10.1186/1746-1596-8-151

Open Data